Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 1
2013 2
2014 4
2015 2
2016 4
2017 2
2018 3
2019 7
2020 8
2021 6
2022 16
2023 13
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

67 results

Results by year

Filters applied: . Clear all
Page 1
Artificial intelligence-based pathology as a biomarker of sensitivity to atezolizumab-bevacizumab in patients with hepatocellular carcinoma: a multicentre retrospective study.
Zeng Q, Klein C, Caruso S, Maille P, Allende DS, Mínguez B, Iavarone M, Ningarhari M, Casadei-Gardini A, Pedica F, Rimini M, Perbellini R, Boulagnon-Rombi C, Heurgué A, Maggioni M, Rela M, Vij M, Baulande S, Legoix P, Lameiras S; HCC-AI study group; Bruges L, Gnemmi V, Nault JC, Campani C, Rhee H, Park YN, Iñarrairaegui M, Garcia-Porrero G, Argemi J, Sangro B, D'Alessio A, Scheiner B, Pinato DJ, Pinter M, Paradis V, Beaufrère A, Peter S, Rimassa L, Di Tommaso L, Vogel A, Michalak S, Boursier J, Loménie N, Ziol M, Calderaro J. Zeng Q, et al. Lancet Oncol. 2023 Dec;24(12):1411-1422. doi: 10.1016/S1470-2045(23)00468-0. Epub 2023 Nov 8. Lancet Oncol. 2023. PMID: 37951222
Molecular Markers of Response to Anti-PD1 Therapy in Advanced Hepatocellular Carcinoma.
Haber PK, Castet F, Torres-Martin M, Andreu-Oller C, Puigvehí M, Miho M, Radu P, Dufour JF, Verslype C, Zimpel C, Marquardt JU, Galle PR, Vogel A, Bathon M, Meyer T, Labgaa I, Digklia A, Roberts LR, Mohamed Ali MA, Mínguez B, Citterio D, Mazzaferro V, Finkelmeier F, Trojan J, Özdirik B, Müller T, Schmelzle M, Bejjani A, Sung MW, Schwartz ME, Finn RS, Thung S, Villanueva A, Sia D, Llovet JM. Haber PK, et al. Among authors: digklia a. Gastroenterology. 2023 Jan;164(1):72-88.e18. doi: 10.1053/j.gastro.2022.09.005. Epub 2022 Sep 12. Gastroenterology. 2023. PMID: 36108710 Free article.
A Review of Ultrasound-Mediated Checkpoint Inhibitor Immunotherapy.
Rivera J, Digklia A, Christou AS, Anibal J, Vallis KA, Wood BJ, Stride E. Rivera J, et al. Among authors: digklia a. Ultrasound Med Biol. 2024 Jan;50(1):1-7. doi: 10.1016/j.ultrasmedbio.2023.08.019. Epub 2023 Oct 3. Ultrasound Med Biol. 2024. PMID: 37798210 Free article. Review.
Organoids: A New Chapter in Sarcoma Diagnosis and Treatment.
Psilopatis I, Kokkali S, Palamaris K, Digklia A, Vrettou K, Theocharis S. Psilopatis I, et al. Among authors: digklia a. Int J Mol Sci. 2022 Sep 24;23(19):11271. doi: 10.3390/ijms231911271. Int J Mol Sci. 2022. PMID: 36232574 Free PMC article. Review.
[2021 Oncology update].
Meyer ML, Chrysou K, Stamatiou A, Gilabert M, Herrera Gomez RG, Latifyan S, Masmoudi S, Mederos N, Perrinjaquet C, Berthold D, Bouchaab H, Cristina V, Digklia A, Michielin O, Orcurto A, Sarivalasis A, Stravodimou A, Wagner AD, Zaman K, Peters S, Jankovic J. Meyer ML, et al. Among authors: digklia a. Rev Med Suisse. 2022 Feb 2;18(767):182-186. doi: 10.53738/REVMED.2022.18.767.182. Rev Med Suisse. 2022. PMID: 35107893 French.
Clear cell sarcoma: state-of-the art and perspectives.
Wetterwald L, Riggi N, Kyriazoglou A, Dei Tos G, Dei Tos A, Digklia A. Wetterwald L, et al. Among authors: digklia a. Expert Rev Anticancer Ther. 2023 Mar;23(3):235-242. doi: 10.1080/14737140.2023.2183846. Epub 2023 Feb 27. Expert Rev Anticancer Ther. 2023. PMID: 36811446 Review.
Efficacy of Eribulin in Soft Tissue Sarcomas.
Phillips E, Jones RL, Huang P, Digklia A. Phillips E, et al. Among authors: digklia a. Front Pharmacol. 2022 Mar 30;13:869754. doi: 10.3389/fphar.2022.869754. eCollection 2022. Front Pharmacol. 2022. PMID: 35444542 Free PMC article. Review.
A differential process mining analysis of COVID-19 management for cancer patients.
Cuendet MA, Gatta R, Wicky A, Gerard CL, Dalla-Vale M, Tavazzi E, Michielin G, Delyon J, Ferahta N, Cesbron J, Lofek S, Huber A, Jankovic J, Demicheli R, Bouchaab H, Digklia A, Obeid M, Peters S, Eicher M, Pradervand S, Michielin O. Cuendet MA, et al. Among authors: digklia a. Front Oncol. 2022 Dec 7;12:1043675. doi: 10.3389/fonc.2022.1043675. eCollection 2022. Front Oncol. 2022. PMID: 36568192 Free PMC article.
67 results